PENPenumbra, Inc.Health Care
$321.68EarningsNov 4, 2026
1D—1W—1M—3M—1Y—
Market cap$12.7BCompany infoRevenue$1.5B52-wk range$226 – $359IndustryMedical - DevicesWebsitepenumbrainc.comRelated—
Yahoo
EDGAR
CNN
FinvizMarket Beat
Perform
n/a
1 Year
n/a1 Month
n/a1 Week
n/a1 Day
Rank Durability
Persist
n/a
1 Year
n/a6 Month
n/a3 Month
n/aTrend Hold
Business Beat
Profit
n/a
Composite
n/aRevenue
n/aMargin
n/aCash Flow
Money Flow
Pressure
n/a
60 Day
n/a30 Day
n/a5 Day
n/a2 Day
▲ +26.0% · 1YSPY
Weekly rank vs S&P 500 · 52wk
Not enough history to plot
ValuationHow the price is priced — vs cohort and vs its own past
MetricValueUnivSect5-yr range
P / E79.0×77
61
1915
P / S8.5×1215
6
14
P / FCF59.0×107
57
26446
EV / EBITDA54.3×55
46
1522
P / E (fwd)———
ProfitabilityMargins and returns on capital
MetricValueUnivSect5-yr range
Gross margin67.8%7966
63%
68%
Operating margin12.4%3941
-5%
13%
Net margin10.7%4959
-4%
13%
ROE11.3%4149
-3%
14%
ROIC9.6%5254
-3%
11%
Financial healthLeverage and liquidity
MetricValueUnivSect5-yr range
Debt / equity0.009794
0.0
0.0
Net debt / EBITDA-3.0×9289
Current ratio5.759491
Interest coverage144.2×8985
Per shareTTM, with year-over-year change
Revenue / share$38.03▲ +18%
EPS (diluted)$4.07▲ +8%
FCF / share$5.46▲ +34%
Est. EPS growth (fwd)—